Antibiotic prophylaxis with acute pancreatitis

Česká verzia

Authors: J. Špičák
Authors place of work: Klinika hepatogastroenterologie, IKEM, Praha
Published in the journal: Gastroent Hepatol 2012; 66(3): 196-201
Category: Clinical and Experimental Gastroenterology: Review Article

Summary

Necrotizing pancreatitis continues to be associated with considerable morbidity and mortality. The serious risk factor is pancreatic infection, which appears most often after the third week through the process of bacterial translocation. The question of antibiotic prophylaxis thus appears to be a relevant issue. The group of studies dealing with the pharmacokinetics ascertained variable penetration into the pancreas and variable potential effect against presumed bacterial infection. In clinical studies, ciprofloxacin with metronidazole, imipenem, meropenem and cephalosporins were most often administered. Most valuable are the randomized studies with ciprofloxacin, imipenem and meropenem, which did not prove the effect of antibiotic prophylaxis. Similarly, we did not confirm the contribution of antibiotic prophylaxis in our two studies. The prospective studies were evaluated in several meta-analyses. The early meta-analyses recommended the antibiotic prophylaxis, the other, involving the most valuable randomized trials, did not. The studies are in agreement that despite the antibiotic prophylaxis the infection of pancreatic necrosis and also extra-pancreatic infections appear often. No one study proved an influence on the course of the disease in association with its severity. In mild pancreatitis, antibiotic prophylaxis is not justified. In case of severe pancreatitis associated with SIRS and organ failure, antibiotic prevention is a matter of individual choice. The clinical condition, markers of inflammation, bacteriological examination and the results of imaging methods are continuously evaluated. According to the author’s personal experience, the exceptions are pancreatitis after ERCP and traumatic pancreatitis, where the infection is directly spread. Here, the antibiotics should be given routinely and immediately. The most frequently recommended antibiotic regimes are ciprofloxacin in combination with metronidazole or carbapenems.

Key words:
acute pancreatitis – antibiotics – prophylaxis

Zdroje

1. Barie PS. A critica1 review of antibiotic prophylaxis in severe acute pancreatitis. Am J Surg 1996; 172(6A): 38S–43S.

2. Büchler MW, Malfertheiner P, Friess H et al. Human pancreatic tissue concentration of bactericidal antibiotics. Gastroenterology 1992;103(6): 1902–1908.

3. Finch WT, Sawyers JL, Schenker SA. A prospective study to determine the efficacy of antibiotics in acute pancretitis. Ann Surg 1976; 183(6): 667–672.

4. Ho HS, Frey CF. The role of antibiotic prophylaxis in severe acute pancreatitis. Arch Surg 1997; 132(5): 487–493.

5. Pederzoli P, Bassi C, Vesentini S et al. A randomized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem. Surg Gynecol Obstet 1993; 176(5): 480–483.

6. Delcensiere R, Yzet T, Ducroix JP. Prophylactic antibiotics in treatment of severe acute a1coholic pancreatitis. Pancreas 1996; 13(2): 190–195.

7. Sainio A, Kempainen E, Puolakkainen P et al. Early antibiotic treatment in acute necrotising pancreatitis. Lancet 1995; 346(8976): 663–667.

8. Schwarz M, Insenmann R, Mayer H et al. Antibiotic use in necrotizing pancreatitis. Results of a controlled study. Dtsch Med Wochenschr 1997; 122(12): 356–361.

9. Luiten EJT, Hop WCJ, Lanje JF et al. A controlled clinical trial of selective decontamination for the treatment of severe acute pancreatitis. Ann Surg 1995; 222(1): 57–65.

10. Takeda K, Matsumo S, Sunamura M et al. Continuous regional arterial infusion of protease inhibitor and antibiotics in acut necrotizing pancreatitis. Am J Surg 1996; 171(4): 394–398.

11. Mai G, Gloor B, Uhl W et al. Routine antibiotic prophylaxis in necrotizing pancreatitis increased gram-positive infectious. Digestion 1999; 60: 360–389.

12. Bassi C, Falconi M, Talamini G et al. Controlled trial of pefloxacin vs. imipenem in severe acute pancreatitis. Gastroenterology 1998; 115(6): 1513–1517.

13. Nordback I, Sand J, Saaristo R et al. Early treatment with antibiotics reduces the need for surgery in acute necrotizing pancreatitis – a single-center randomized study. J Gastroeneterol Surg 2001; 5(2): 113–120.

14. Manes G, Uomo I, Manchise A et al. Timing of antibiotic prophylaxis in acute pancreatitis: a controlled randomized study with meropenem. Am J Gastroenterol 2006; 101(6): 1348–1353.

15. Isenmann R, Rünzi M, Kron M et al. Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo-controlled, double-blind trial. Gastroenterology 2004; 126(4): 997–1004.

16. Delinger EP, Tellado JM, Soto NE et al. Early antibiotic treatment for severe acute necrotizing pancreatitis: a randomized, double-blind placebo-controlled study. Ann Surg 2007; 245(5): 674–683.

17. Rokke O, Harbitz TB, Liljedal J et al. Early treatment of severe pancreatitis with imipenem. A prospective randomized clinical trial. Scand J Gastroenterol 2007; 42(6): 771–776.

18. Xue P, Dewng LH, Zhang ZD et al. Effect of antibiotic prophylaxis on acute necrotizing pancreatitis: results of a randomized controlled trial. J Gastroenterol Hepatol 2009; 24(5): 736–742.

19. García-Barrasa A, Borobia FG, Pallares R et al. A double-blind, placebo-controlled trial of ciprofloxacin prophylaxis in patients with acute necrotizing pancreatitis. J Gastrointest Surg 2009; 13(4): 768–774.

20. Špičák J, Hubaczová M, Antoš F et al. Antibiotic prophylaxis of infectious complications in severe acute pancreatitis: Preliminary results of controlled study. Digestion 2000; 61: A287.

21. Gloor B, Schmidt O, Uhl W et al. Acute pancreatitis: threat of fungal infection. Pancreatology 2001; 1(3): 213–216.

22. Golub R, Siddiqi F, Pohl D. Role of antibiotics in acute pancreatitis: a metaanalysis. J Gastrointest Surg 1998; 2(6): 496–503.

23. Sharma VK, Howden CW. Prophylactic antibiotic administration reduces sepsis and mortality in acute necrotizing pancreatitis: a meta-analysis. Pancreas 2001; 22(1): 28–31.

24. Villatoro E, Bassi C, Larvin M. Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis (Review). The Cochrane Library 2006; 4: CD002941.

25. Heinrich S, Schafer M, Rousson V et al. Evidence-based treatment of acute pancreatitis. Ann Surg 2006; 243(2): 154–168.

26. Mazaki T, Ishii Y, Takayama T. Meta-analysis of prophylacticantibiotic use in acute necrotizing pancreatitis. Br J Surg 2006; 93(6): 674–684.

27. Villatoro E, Mulla M, Larvin M. Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis (Review). The Cochrane Library 2010; 5: CD002941.

28. Wittau M, Mayer B, Scheele J et al. Systematic review and metaanalysis of antibiotic prophylaxis in severe acute pancreatitis. Scand J Gastroenterol 2011; 46(3): 261–270.

29. Yao L, Huang X, Li Y et al. Prophylactic antibiotic reduce pancreatic necrosis in acute pancreatitis.Dig Surg 2010; 27(6): 442–449.